SpaceVision PLIF, OLIF, TLIF
510(k) K153783
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK153783 | Date4 May 2016 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- SpaceVision® PLIF, SpaceVision® OLIF, SpaceVision® TLIF
- 510(k) Number
- FDA Product Code
- MAX
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3080
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 20 Sep 2026
The SpaceVision PLIF, OLIF, and TLIF are intervertebral body fusion cages designed for lumbar spinal stabilization. These devices are intended to promote spinal fusion, restrict motion, and alleviate pain in patients with degenerative disc disease (DDD) at one or two continuous levels from L2 to S1. They are categorized under the FDA’s product code MAX and fall under the Orthopedic advisory committee classification. The devices are engineered to address discogenic back pain confirmed by clinical history and radiographic studies.
These fusion cages are supplied by Spinevision S.A. and are classified as substantially equivalent under FDA 510(k) clearance (K153783), granted on May 4, 2016. They are intended for surgical use in spinal procedures, including posterior lumbar interbody fusion (PLIF), oblique lumbar interbody fusion (OLIF), and transforaminal lumbar interbody fusion (TLIF). The devices are not described as single-use or reusable, nor is MRI safety or sterility explicitly stated in the available data. Storage and handling instructions are not provided in the specifications.